P3 Health Partners Inc. (PIII)
| Market Cap | 20.88M |
| Revenue (ttm) | 1.46B |
| Net Income (ttm) | -147.95M |
| Shares Out | 7.21M |
| EPS (ttm) | -45.26 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8,038 |
| Open | 2.758 |
| Previous Close | 2.700 |
| Day's Range | 2.730 - 2.960 |
| 52-Week Range | 1.520 - 11.300 |
| Beta | 0.56 |
| Analysts | Buy |
| Price Target | 9.00 (+210.88%) |
| Earnings Date | May 14, 2026 |
About PIII
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. The company operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada. [Read more]
Financial Performance
In 2025, P3 Health Partners's revenue was $1.46 billion, a decrease of -2.76% compared to the previous year's $1.50 billion. Losses were -$147.95 million, 8.91% more than in 2024.
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for PIII stock is "Buy." The 12-month stock price target is $9.0, which is an increase of 210.88% from the latest price.
News
P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Co...
P3 Health Partners Earnings Call Transcript: Q4 2025
Guidance for 2026 targets a $10 million Adjusted EBITDA midpoint, a $170 million improvement year-over-year, driven by contract, operational, and cost structure enhancements. Expansion into a new Medicare Advantage market adds 29,000 members and a multi-year glide path to risk.
P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financi...
P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Co...
P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners (“P3”) (NASDAQ: PIII) and Commonwealth Primary Care ACO (Commonwealth) recently announced the formation of a Joint Venture Management Services Orga...
P3 Health Partners to Present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference
Henderson, Nevada--(Newsfile Corp. - November 24, 2025) - P3 Health Partners Inc. (NASDAQ: PIII) ("P3"), a patient-centered and physician-led population health management company, today announced that...
P3 Health Partners Earnings Call Transcript: Q3 2025
Q3 results reflect a transitional year with stable medical cost trends, improved provider alignment, and a 6% increase in capitated revenue. Despite a $45.9M adjusted EBITDA loss, operational improvements and contract renegotiations position the business for profitability in 2026.
P3 Health Partners Announces Third Quarter 2025 Results
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financi...
P3 Health Partners Schedules Third Quarter 2025 Earnings Release and Conference Call
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Co...
P3 Health Partners to Participate in the Jefferies Healthcare Services Conference
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in ...
P3 Health Partners Transcript: IAccess Alpha Virtual Best Ideas Fall Conference 2025
Operating in four states, the organization is focused on value-based care for seniors, leveraging a full-risk model and data-driven platform to drive profitability. Significant EBITDA improvements have been achieved, with further gains targeted for 2026, and membership growth expected to resume after network optimization.
Catalyst Solutions Announces Successful Launch of P3 Implementation Across Four States
GREENWOOD VILLAGE, Colo. , Aug. 25, 2025 /PRNewswire/ -- Catalyst Solutions is thrilled to announce the successful go-live of the Professional Health Partners Services (P3) Implementation, which offic...
P3 Health Partners Earnings Call Transcript: Q2 2025
Q2 results showed improved operational execution, with normalized EBITDA loss narrowing and medical cost trends flat year-over-year. Revised 2025 guidance reflects prior period headwinds and a single underperforming payer, but significant EBITDA improvement is expected in 2026 from contract, operational, and market changes.
P3 Health Partners Announces Second Quarter 2025 Results
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financi...
P3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference Call
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to re...
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION
P3 Health Partners Earnings Call Transcript: Q1 2025
Q1 2025 revenue declined 4% year-over-year to $373 million, with membership down 8% as part of a strategic exit from unprofitable plans. Operational improvements and contract renegotiations drove an 8% increase in per-member funding, and three of four markets reached break-even or better.
P3 Health Partners Announces First Quarter 2025 Results
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financi...
P3 Health Partners Schedules First Quarter 2025 Earnings Release and Conference Call
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to re...
P3 Health Partners to Participate in the 24th Annual Needham Virtual Healthcare Conference
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in ...
P3 Health Partners Earnings Call Transcript: Q4 2024
Revenue grew 18% year-over-year to $1.5B in 2024, with membership up 13% and improved operational efficiencies. 2025 guidance reaffirms revenue of $1.35B–$1.5B and targets profitability, supported by cost controls, benefit design changes, and expanded specialty contracts.
P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient- centered and physician-led population health management company, today announced its financ...
P3 Health Partners to Report Fourth Quarter and Full Year 2024 Financial Results on March 27
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to re...
P3 Health Partners to Participate in the TD Cowen 45th Annual Health Care Conference
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in ...
P3 Health Partners Provides Preliminary 2025 Guidance and Announces Proposed Financing Transaction
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered, physician-led population health management company, is targeting profitability in ...